Mirae Asset Global Investments Co., Ltd. Century Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$3.19 - $5.32 $35,504 - $59,211	11,130 New	11,130 $46,000
Q2 2023 Aug 10, 2023	SELL	$2.91 - $3.53 $314 - $381	-108 Reduced 0.86%	12,477 $39,000
Q1 2023 May 04, 2023	SELL	$3.4 - $5.11 $125 - $189	-37 Reduced 0.29%	12,585 $43,000
Q4 2022 Feb 09, 2023	BUY	$4.84 - $11.58 $61,090 - $146,162	12,622 New	12,622 $64,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $61.8M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.